CHAMPIONS ONCOLOGY, INC. Balance Sheet
CSBR|14 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
CHAMPIONS ONCOLOGY, INC. had $32M in total assets and $4M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | - | - | - | $3.2M | $856.0K | $2.6M | $9.4M | $5.9M | $9.6M | $4.8M | $4.8M |
| Accounts Receivable | $9.5M | $9.5M | $9.5M | $7.0M | $7.0M | $4.8M | $4.4M | $3.9M | $2.3M | $1.3M | $1.1M | $1.3M | $500.0K | $584.0K |
| Current Assets | $22.4M | $13.6M | $19.5M | $19.7M | $12.6M | $13.5M | $7.9M | $5.1M | $5.9M | $4.3M | $10.8M | $7.6M | $10.4M | $5.5M |
| PP&E (Net) | $4.4M | - | $7.2M | $7.1M | $6.1M | $4.0M | $2.5M | $2.1M | $1.2M | $618.0K | $452.0K | $434.0K | $414.0K | $560.0K |
| Goodwill | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $669.0K | $669.0K | $669.0K | $669.0K | $669.0K | $669.0K | $669.0K | $669.0K |
| Total Assets | $32.3M | $26.1M | $34.3M | $35.4M | $27.6M | $20.8M | $11.3M | $8.1M | $8.0M | $5.8M | $12.0M | $8.9M | $11.7M | $6.9M |
| Current Liabilities | $23.9M | $21.5M | $21.7M | $17.5M | $11.2M | $12.3M | $8.0M | $7.5M | $7.4M | $5.3M | $3.8M | $3.7M | $2.9M | $3.5M |
| Shareholders' Equity | $3.8M | -$1.9M | $9.1M | $7.4M | $5.1M | $5.1M | $2.1M | $400.0K | $238.0K | $8.1M | $3.2M | -$9.2M | -$5.3M | -$5.3M |